156 related articles for article (PubMed ID: 37220145)
1. Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
Gatti A; Zizzo G; De Paschale M; Tamburello A; Castelnovo L; Faggioli PM; Clerici P; Brando B; Mazzone A
PLoS One; 2023; 18(5):e0285728. PubMed ID: 37220145
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.
Tormo N; Giménez E; Martínez-Navarro M; Albert E; Navalpotro D; Torres I; Gimeno C; Navarro D
Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):657-662. PubMed ID: 35165804
[TBL] [Abstract][Full Text] [Related]
3. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2-reactive IFN-γ-producing CD4
Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
[TBL] [Abstract][Full Text] [Related]
5. Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals.
Jaganathan S; Stieber F; Rao SN; Nikolayevskyy V; Manissero D; Allen N; Boyle J; Howard J
Infect Dis Ther; 2021 Dec; 10(4):2765-2776. PubMed ID: 34435336
[TBL] [Abstract][Full Text] [Related]
6. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
[TBL] [Abstract][Full Text] [Related]
8. Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
Sedegah M; Porter C; Goguet E; Ganeshan H; Belmonte M; Huang J; Belmonte A; Inoue S; Acheampong N; Malloy AMW; Hollis-Perry M; Jackson-Thompson B; Ramsey KF; Alcorta Y; Maiolatesi SE; Wang G; Reyes AE; Illinik L; Sanchez-Edwards M; Burgess TH; Broder CC; Laing ED; Pollett SD; Villasante E; Mitre E; Hollingdale MR
PLoS One; 2022; 17(10):e0276241. PubMed ID: 36251675
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4
Aiello A; Coppola A; Vanini V; Petrone L; Cuzzi G; Salmi A; Altera AMG; Tortorella C; Gualano G; Gasperini C; Scolieri P; Beccacece A; Vita S; Bruzzese V; Lorenzetti R; Palmieri F; Nicastri E; Goletti D
Int J Infect Dis; 2022 Sep; 122():841-849. PubMed ID: 35878802
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.
Rakshit S; Adiga V; Ahmed A; Parthiban C; Chetan Kumar N; Dwarkanath P; Shivalingaiah S; Rao S; D'Souza G; Dias M; Maguire TJA; Doores KJ; Zoodsma M; Geckin B; Dasgupta P; Babji S; van Meijgaarden KE; Joosten SA; Ottenhoff THM; Li Y; Netea MG; Stuart KD; De Rosa SC; McElrath MJ; Vyakarnam A
Front Immunol; 2022; 13():985938. PubMed ID: 36268023
[TBL] [Abstract][Full Text] [Related]
11. High Frequencies of Functional Virus-Specific CD4
Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
Front Immunol; 2021; 12():748881. PubMed ID: 34858405
[TBL] [Abstract][Full Text] [Related]
12. Helminth antigens differentially modulate the activation of CD4
Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
[TBL] [Abstract][Full Text] [Related]
13. An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV-2 immune individuals.
Altosole T; Rotta G; Uras CRM; Bornheimer SJ; Fenoglio D
J Immunol Methods; 2023 Apr; 515():113443. PubMed ID: 36842524
[TBL] [Abstract][Full Text] [Related]
14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity.
Dourdouna MM; Tatsi EB; Syriopoulou V; Michos A
Diagn Microbiol Infect Dis; 2023 Jul; 106(3):115948. PubMed ID: 37094435
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ
Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
[TBL] [Abstract][Full Text] [Related]
17. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.
Zhang J; Lin H; Ye B; Zhao M; Zhan J; Dong S; Guo Y; Zhao Y; Li M; Liu S; Zhang H; Xiao W; Guo Y; Yue C; Zhang D; Yang M; Zhang J; Quan C; Shi W; Liu X; Liu P; Jiang Y; Wu G; Gao GF; Liu WJ
Clin Infect Dis; 2022 Aug; 75(1):e1072-e1081. PubMed ID: 34609506
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents.
Koerber N; Priller A; Yazici S; Bauer T; Cheng CC; Mijočević H; Wintersteller H; Jeske S; Vogel E; Feuerherd M; Tinnefeld K; Winter C; Ruland J; Gerhard M; Haller B; Christa C; Zelger O; Roggendorf H; Halle M; Erber J; Lingor P; Keppler O; Zehn D; Protzer U; Knolle PA
Nat Commun; 2022 Jan; 13(1):153. PubMed ID: 35013191
[TBL] [Abstract][Full Text] [Related]
19. Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
Kirchner T; Heinrich S; Bonifacius A; Engel B; Ruhl L; Pink I; Thomas N; Martens J; Hoeper MM; Blasczyk R; Wedemeyer H; Jaeckel E; Li Y; Falk CS; Eiz-Vesper B; Taubert R
PLoS One; 2022; 17(11):e0276929. PubMed ID: 36322587
[TBL] [Abstract][Full Text] [Related]
20. Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.
Kudryavtsev IV; Arsentieva NA; Korobova ZR; Isakov DV; Rubinstein AA; Batsunov OK; Khamitova IV; Kuznetsova RN; Savin TV; Akisheva TV; Stanevich OV; Lebedeva AA; Vorobyov EA; Vorobyova SV; Kulikov AN; Sharapova MA; Pevtsov DE; Totolian AA
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]